BRPI0721078A2 - POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO - Google Patents

POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO

Info

Publication number
BRPI0721078A2
BRPI0721078A2 BRPI0721078-7A2A BRPI0721078A BRPI0721078A2 BR PI0721078 A2 BRPI0721078 A2 BR PI0721078A2 BR PI0721078 A BRPI0721078 A BR PI0721078A BR PI0721078 A2 BRPI0721078 A2 BR PI0721078A2
Authority
BR
Brazil
Prior art keywords
multimeric
domain
modified
polypeptides including
receiver polypeptides
Prior art date
Application number
BRPI0721078-7A2A
Other languages
English (en)
Inventor
Phillip Mark Hogarth
Bruce David Wines
Original Assignee
Suppremol Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2006/001890 external-priority patent/WO2007068047A1/en
Priority claimed from US11/762,664 external-priority patent/US8354109B2/en
Application filed by Suppremol Gmbh filed Critical Suppremol Gmbh
Publication of BRPI0721078A2 publication Critical patent/BRPI0721078A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0721078-7A2A 2006-12-13 2007-12-13 POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO BRPI0721078A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/AU2006/001890 WO2007068047A1 (en) 2005-12-13 2006-12-13 Multimeric fc receptor polypeptides
US11/762,664 US8354109B2 (en) 2005-12-13 2007-06-13 Multimeric Fc receptor polypeptides
PCT/AU2007/001934 WO2008070927A1 (en) 2006-12-13 2007-12-13 Multimeric fc receptor polypeptides including a modified fc domain

Publications (1)

Publication Number Publication Date
BRPI0721078A2 true BRPI0721078A2 (pt) 2014-10-07

Family

ID=40961582

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0721078-7A2A BRPI0721078A2 (pt) 2006-12-13 2007-12-13 POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO

Country Status (6)

Country Link
EP (1) EP2099819A4 (pt)
JP (1) JP2010512154A (pt)
BR (1) BRPI0721078A2 (pt)
CA (1) CA2671732A1 (pt)
RU (1) RU2009126545A (pt)
WO (1) WO2008070927A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718836B (zh) * 2009-04-24 2014-04-16 上海交通大学医学院附属瑞金医院 一种短肽及含有其的免疫抑制剂和应用
EP2492689B8 (en) * 2011-02-22 2013-12-25 Bernhard-Nocht-Institut für Tropenmedizin Detection of antibodies using an improved immune complex (IC) ELISA
CN103911387A (zh) * 2013-01-08 2014-07-09 深圳先进技术研究院 含鼠lgG2a Fc标签的真核表达载体及其构建方法
KR101685532B1 (ko) * 2016-04-26 2016-12-13 한국프라임제약주식회사 혈관내피성장인자 수용체 융합단백질
WO2022252131A1 (en) * 2021-06-01 2022-12-08 Virogin Biotech Canada Ltd. Multivalent recombinant ace2 and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100453877B1 (ko) * 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
EP1596804A4 (en) * 2003-01-13 2008-02-06 Macrogenics Inc SOLUBLE FCyR FUSION PROTEINS AND METHODS OF USE
JP2008512083A (ja) * 2004-02-10 2008-04-24 ジ・オースティン・リサーチ・インスティテュート Ｆｃ受容体の結晶構造およびモデルならびにＦｃ受容体モジュレーター化合物の設計および同定におけるそれらの使用
WO2007068047A1 (en) * 2005-12-13 2007-06-21 Trillium Therapeutics Inc Multimeric fc receptor polypeptides

Also Published As

Publication number Publication date
EP2099819A1 (en) 2009-09-16
EP2099819A4 (en) 2010-03-17
CA2671732A1 (en) 2008-06-19
WO2008070927A1 (en) 2008-06-19
JP2010512154A (ja) 2010-04-22
RU2009126545A (ru) 2011-01-20

Similar Documents

Publication Publication Date Title
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
BRPI0812593A2 (pt) sensor de posição angular
BRPI0815935A2 (pt) sensor de posição
BRPI0813942A2 (pt) Polipeptídio ace2
ATE467622T1 (de) Pyrazin-2-carboxamid-derivate als cb2- rezeptormodulatoren
DE602007003343D1 (de) Neue mikrobiozide
CR10930A (es) Moduladores receptores nicotinicos de acetilcolina
BRPI0819415A2 (pt) Sensor de posição
ITMI20072422A1 (it) Ricevitore ottico
DE502006002891D1 (de) Multifunktionsaggregat
DE602007003126D1 (de) Kapazitiver Sensor
DE602006012929D1 (de) Optischer Empfänger
BRPI0720224A2 (pt) Arilpirazóis substituídos
DE502007004319D1 (de) Fühler
DE602007000058D1 (de) Abdeckeinrichtung
BRPI0810195A2 (pt) Moduladores de gpbar1
DE502007004371D1 (de) Scharnier-Anordnung
BRPI0721078A2 (pt) POLIPEPTÍDEOS DE RECEPTORES Fc MULTIMÉRICOS INCLUINDO UM DOMÍNIO Fc MODIFICADO
DE112007001747A5 (de) Möbelscharnier
BRPI0818631A2 (pt) Cobertura de carril
ATE524461T1 (de) Neue substituierte piperidylpropanthiole
BRPI0712951A2 (pt) Unidade de aplicação
DE602007008589D1 (de) Pyridooxazepin-progesteronrezeptor-modulatoren
DE602007003896D1 (de) Schalteranordnung
FR2900624B1 (fr) Traverse de pavillons multifonctions

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]